Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Erika Holmberg"'
Autor:
Westyn Branch-Elliman, Ryan Ferguson, Gheorghe Doros, Patricia Woods, Sarah Leatherman, Judith Strymish, Rupak Datta, Rekha Goswami, Matthew D Jankowich, Nishant R Shah, Thomas H Taylor, Sarah T Page, Sara J Schiller, Colleen Shannon, Cynthia Hau, Maura Flynn, Erika Holmberg, Karen Visnaw, Rupali Dhond, Mary Brophy, Paul A Monach
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0263591 (2022)
Importance and objectiveThe aim of this pragmatic, embedded, adaptive trial was to measure the effectiveness of the subcutaneous anti-IL-6R antibody sarilumab, when added to an evolving standard of care (SOC), for clinical management of inpatients wi
Externí odkaz:
https://doaj.org/article/0f93913ce462481c84ad214cf1534dd7
Autor:
Patricia Woods, Maura Flynn, Paul Monach, Karen Visnaw, Sara Schiller, Erika Holmberg, Sarah Leatherman, Ryan Ferguson, Westyn Branch-Elliman
Publikováno v:
Contemporary Clinical Trials Communications, Vol 23, Iss , Pp 100804- (2021)
Background and objective: The communicable nature of many infectious diseases, including SARS-CoV-2, creates challenges for implementing and obtaining regulatory-compliant written informed consent. The goal of this project was to identify and evaluat
Externí odkaz:
https://doaj.org/article/fdfcb8ff129c442aadde6be4200312db
Autor:
Samira Reyes Dassum, Ryan Ferguson, Patricia Woods, Maura Flynn, Karen Visnaw, Erika Holmberg, Sara Schiller, Colleen Shannon, Mary Brophy, Paul Monach, Sarah Leatherman, Westyn Branch-Elliman
Publikováno v:
Contemporary Clinical Trials. 126:107082
Autor:
Westyn Branch-Elliman, Ryan Ferguson, Gheorghe Doros, Patricia Woods, Sarah Leatherman, Judith Strymish, Rupak Datta, Rekha Goswami, Matthew D. Jankowich, Nishant R. Shah, Thomas H. Taylor, Sarah T. Page, Sara J. Schiller, Colleen Shannon, Cynthia Hau, Maura Flynn, Erika Holmberg, Karen Visnaw, Rupali Dhond, Mary Brophy, Paul A. Monach
Publikováno v:
PloS one. 17(2)
Importance and objective The aim of this pragmatic, embedded, adaptive trial was to measure the effectiveness of the subcutaneous anti-IL-6R antibody sarilumab, when added to an evolving standard of care (SOC), for clinical management of inpatients w
Autor:
Sarah Leatherman, Erika Holmberg, Karen Visnaw, Paul A. Monach, Ryan Ferguson, Sara Schiller, Patricia Woods, Maura Flynn, Westyn Branch-Elliman
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 23, Iss, Pp 100804-(2021)
Contemporary Clinical Trials Communications, Vol 23, Iss, Pp 100804-(2021)
Background and objective The communicable nature of many infectious diseases, including SARS-CoV-2, creates challenges for implementing and obtaining regulatory-compliant written informed consent. The goal of this project was to identify and evaluate
Autor:
Westyn Branch-Elliman, Ryan Ferguson, Gheorghe Doros, Patricia Woods, Sarah Leatherman, Judith Strymish, Rupak Datta, Rekha Goswami, Matthew Jankowich, Nishant Shah, Thomas H Taylor, Sarah T Page, Sara Schiller, Colleen Shannon, Cynthia Hau, Maura Flynn, Erika Holmberg, Karen Visnaw, Rupali Dhond, Mary Brophy, Paul Monach
Publikováno v:
Open Forum Infectious Diseases
Background The aim of this pragmatic, embedded adaptive trial was to measure the effectiveness of subcutaneous sarilumab in addition to an evolving standard of care for clinical management of inpatients with moderate to severe COVID-19 disease (NCT04
Autor:
Joanne Valeriano-Marcet, Amy Joseph, Ted R. Mikuls, J. Rodrigues, Thomas Olenginski, Cynthia Weaver, Salahuddin Kazi, Pamela E. Prete, Ciaran S. Phibbs, James R. O'Dell, Peter D. Kent, Keri Hannagan, Samardeep Gupta, Jay E. Persselin, Keith K. Colburn, Erika Holmberg, Virginia Reddy, David I. Daikh, Joseph Fanciullo, Liam Martin, Gail S. Kerr, Aslam H. Anis, Lynne Peterson, Sarah Leatherman, Karen S. Kolba, Hani El-Gabalawy, Raymond Hausch, Andrew Chow, Andreas M. Reimold, Vivian P. Bykerk, William T. Ayoub, Huiying Sun, Gilles Boire, John M. Davis, David Pugliese, H. Ralph Schumacher, Edward C. Keystone, Mary Brophy, Mahfooz Peshimam, C. Kent Kwoh, Jennifer R. Elliott, J. Carter Thorne, Maren L. Mahowald, Nick Bansback
Publikováno v:
Annals of internal medicine. 167(1)
The RACAT (Rheumatoid Arthritis Comparison of Active Therapies) trial found triple therapy to be noninferior to etanercept-methotrexate in patients with active rheumatoid arthritis (RA).To determine the cost-effectiveness of etanercept-methotrexate v
Autor:
Alisa M. Goldstein, Carol Wicking, Georgia Chenevix-Trench, Heidi Hahn, Michael Dean, Brandon J. Wainwright, Allen E. Bale, Igor Vorechovsky, Abirami Chidambaram, David J. Leffell, Peter G. Zaphiropoulos, Kylie Negus, Carolyn Pressman, Susan Shanley, Ian M. Smyth, Bernard Gerrard, Rune Toftgård, Anne Birgitte Undén, Susan Gillies, Mae R. Gailani, Erika Holmberg
Publikováno v:
Karolinska Institutet
The nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder characterized by multiple basal cell carcinomas (BCCs), pits of the palms and soles, jaw keratocysts, a variety of other tumors, and developmental abnormalities. NBCCS